CCRC: Prevention of Post-Prandial Hypoglycemia Using n-3/n-6 PUFA in PCOS
18 Years
45 Years
Female
Polycystic Ovarian Syndrome
Trial Information
CCRC: Prevention of Post-Prandial Hypoglycemia Using n-3/n-6 PUFA in PCOS
The aim is to investigate whether n-3 PUFA's can be used to prevent postprandial
hypoglycemia and its unfavorable consequences, such as stimulation of cortisol and adrenal
androgen secretion, in women with polycystic ovarian syndrome.
Inclusion Criteria:
- Females ages 18-45
- Women who are overweight, and have irregular periods or have been diagnosed with
Polycystic Ovarian Syndrome
Exclusion Criteria:
- Use of oral contraceptives
- Impaired glucose tolerance
- Diabetes mellitus, and any other systemic illnesses such as renal, hepatic,
gastrointestinal, severe hyperlipidemia and hypertension that require medication
- Schizophrenia
- Having a pacemaker
- Current viral infection
- Smoking alcohol intake (more than 2 drinks/week)
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Outcome Measure:
We hope to learn more about the effects of fish oil, flax seed oil, and soybean oil, on blood sugar and insulin levels in PCOS patients
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Sidika Kasim-Karakas, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
UC Davis
Authority:
United States: Institutional Review Board
Study ID:
200715060-1
NCT ID:
NCT00579540
Start Date:
September 2007
Completion Date:
September 2009
Related Keywords:
- Polycystic Ovarian Syndrome
- Polycystic Ovary Syndrome
- Hypoglycemia
Name | Location |
|---|---|
| UC Davis | Sacramento, California 95817 |
